Chan, S C <br/><br/>
Increased interleukin-4 production by atopic mononuclear leukocytes correlates with increased cyclic adenosine monophosphate-phosphodiesterase activity and is reversible by phosphodiesterase inhibition.  [electronic resource] 

 -  The Journal of investigative dermatology  May 1993 
 - 681-4 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0022-202X 
<br/><br/><label>Standard No.: </label>10.1111/1523-1747.ep12472344  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone--pharmacology<br/>Adult<br/>Cyclic AMP--metabolism<br/>Dermatitis, Atopic--metabolism<br/>Humans<br/>Interleukin-4--antagonists & inhibitors<br/>Monocytes--metabolism<br/>Phosphodiesterase Inhibitors--pharmacology<br/>Phosphoric Diester Hydrolases--metabolism<br/>Reference Values